newsfilter
← Latest News
PR Newswire·

Enliven Therapeutics Appoints Kristine Ball to Board of Directors Ahead of Planned Phase 3 Trial Initiation this Year

Accomplished biopharmaceutical executive with extensive experience in corporate strategy, finance and commercial readinessEnliven continues preparation for late-stage development and commercialization, as it plans to